InsiderClue
Insiders · Profile

Paolini John F.

CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International. Filing since 13 Feb 2020. CIK 0001741533

Company
Date
Role
Action
Shares
Amount
Of holding
KNSA Kiniksa Pharmaceuticals International, plc
1 May 2026
CHIEF MEDICAL OFFICER
Sold on a plan
58,424
$3.14M
47.1%
KNSA Kiniksa Pharmaceuticals International, plc
2 Mar 2026
CHIEF MEDICAL OFFICER
Sold on a plan
40,000
$1.79M
39.5%
KNSA Kiniksa Pharmaceuticals International, plc
31 Oct 2025
CHIEF MEDICAL OFFICER
Sold on a plan
82,542
$3.07M
57.4%
KNSA Kiniksa Pharmaceuticals International, plc
6 Aug 2025
CHIEF MEDICAL OFFICER
Sold on a plan
29,325
$954.53K
33.8%
KNSA Kiniksa Pharmaceuticals International, plc
7 May 2025
CHIEF MEDICAL OFFICER
Sold on a plan
200
$5.40K
0.3%
KNSA Kiniksa Pharmaceuticals International, plc
3 Sep 2024
CHIEF MEDICAL OFFICER
Sold on a plan
60,692
$1.58M
53.8%
KNSA Kiniksa Pharmaceuticals International, plc
23 Jul 2024
CHIEF MEDICAL OFFICER
Sold on a plan
22,000
$578.97K
31.5%
KNSA Kiniksa Pharmaceuticals International, plc
1 Mar 2024
CHIEF MEDICAL OFFICER
Sold on a plan
18,844
$410.23K
29.6%
KNSA Kiniksa Pharmaceuticals International, plc
27 Feb 2024
CHIEF MEDICAL OFFICER
Sold on a plan
10,156
$213.58K
18.4%
KNSA Kiniksa Pharmaceuticals International, plc
7 Dec 2023
CHIEF MEDICAL OFFICER
Sold on a plan
28,600
$504.76K
38.9%
KNSA Kiniksa Pharmaceuticals International, plc
5 Sep 2023
CHIEF MEDICAL OFFICER
Sold on a plan
400
$7.01K
0.9%
KNSA Kiniksa Pharmaceuticals International, plc
25 Jul 2023
CHIEF MEDICAL OFFICER
Sold at will
29,000
$555.16K
40.9%
KNSA Kiniksa Pharmaceuticals International, plc
7 Nov 2022
CHIEF MEDICAL OFFICER
Sold, plan not stated
28,357
$430.46K
43.8%
KNSA Kiniksa Pharmaceuticals International, plc
20 Feb 2020
SVP & Chief Medical Officer
Sold, plan not stated
9,803
$185.83K
35.3%
KNSA Kiniksa Pharmaceuticals International, plc
19 Feb 2020
SVP & Chief Medical Officer
Sold, plan not stated
22,477
$410.65K
55.5%
KNSA Kiniksa Pharmaceuticals International, plc
14 Feb 2020
SVP & Chief Medical Officer
Sold, plan not stated
1,039
$19.04K
5.5%
KNSA Kiniksa Pharmaceuticals International, plc
13 Feb 2020
SVP & Chief Medical Officer
Sold, plan not stated
10,277
$187.97K
36.3%
17 decisions on file.